Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › KLRG1 antagonist signaling therapy

KLRG1 antagonist signaling therapy

US Patent 11339222 · Granted May 24, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Interferon beta antibodies and uses thereof2025
Interferon beta antibodies and uses thereof2025
Chemically-defined baculovirus expression system2025
Anti-KLRG1 antibodies2025
Anti-KLRG1 antibodies2025
Antibodies that bind interleukin 13 and methods of use2025
Methods of treating disorders associated with excess or unwanted killer cell lec2024
Methods of treating disorders associated with excess or unwanted killer cell lec2024
Recombinant ROBO2 proteins, compositions, methods and uses thereof2024
Interferon beta antibodies and uses thereof2024
Interferon beta antibodies and uses thereof2024
Anti-ROBO2 antibodies, compositions, methods and uses thereof2022